HEMOLYTICS

PHARMACEUTICALS NAMELY PORE-FORMING AGENTS FOR USE IN THE TREATMENT OF CANCER AND HIV; DRUG DELIVERY SYSTEM COMPRISED PRIMARILY OF PRE-FILLED LIPID OR LIPID BASED CAPSULES FOR USE IN TREATMENT OF CANCER AND HIV; AND BIOTECHNOLOGY PRODUCTS, NAMELY A DRUG CAPSULE